Adalimumab Injection (Adali) – TNF Blocker Monoclonal Antibody
Adalimumab (Adali) is a biologic TNF-α inhibitor designed to reduce inflammation by blocking the activity of tumor necrosis factor, a key cytokine involved in autoimmune disease progression. By targeting TNF-α, Adalimumab helps control chronic inflammation, reduce tissue damage, and improve long-term disease outcomes.
Therapeutic Indications of Adalimumab InjectionTofacitinib Tablets – JAK Inhibitor for Psoriasis & Vitiligo (Adali) – TNF Blocker Monoclonal Antibody
Adalimumab injection is indicated for the treatment of:
-
Rheumatoid Arthritis
-
Juvenile Idiopathic Arthritis
-
Psoriatic Arthritis
-
Ankylosing Spondylitis
-
Adult Crohn’s Disease
-
Pediatric Crohn’s Disease
-
Ulcerative Colitis
-
Plaque Psoriasis
-
Hidradenitis Suppurativa
Mechanism of Action
Adalimumab (Adali) is a recombinant human IgG1 monoclonal antibody that binds specifically to TNF-α, preventing it from interacting with TNF receptors. This inhibition suppresses inflammatory signaling pathways responsible for autoimmune disease activity.
Dosage & Administration (Adalimumab – Adali)
Route of Administration:
Subcutaneous injection (under the skin)
Dosage:
The dose of Adalimumab (Adali) varies depending on the disease being treated, patient age, and clinical response. Treatment should always be initiated and monitored by a specialist.
🔹 Common Adult Dosing (General Reference)
-
Rheumatoid Arthritis / Psoriatic Arthritis / Ankylosing Spondylitis:
40 mg every other week -
Plaque Psoriasis:
Initial dose: 80 mg
Maintenance dose: 40 mg every other week -
Crohn’s Disease / Ulcerative Colitis:
Induction followed by 40 mg every other week as maintenance -
Hidradenitis Suppurativa:
Induction dosing followed by regular maintenance injections as prescribed
🔹 Pediatric Use
Dose is weight-based and determined by a healthcare professional.
⚠️ Important Notes
-
Dose adjustment may be required based on response and tolerability
-
Patients should be screened for infections (e.g., TB) before starting therapy
-
Regular medical monitoring is recommended
Storage Instructions
-
Store at 2°C–8°C (refrigerated)
-
Do not freeze
-
Protect from light
-
Keep out of reach of children
Why Choose Adali (Adalimumab)
-
Proven TNF-α inhibition
-
Broad autoimmune disease coverage
-
Suitable for long-term disease control
-
Export-quality biologic manufacturing
-
Trusted alternative to originator brands
Frequently Asked Questions (FAQ)
What is Adalimumab used for?
Adalimumab is used to treat autoimmune and inflammatory diseases such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriasis, and hidradenitis suppurativa.
Is Adalimumab a steroid?
No. Adalimumab is not a steroid. It is a biologic monoclonal antibody that targets TNF-α.
How is Adalimumab administered?
Adalimumab is given as a subcutaneous injection, usually at regular intervals as prescribed.
Is Adalimumab safe for long-term use?
Yes, when used under specialist supervision with appropriate monitoring.
Do I need a prescription to buy Adalimumab?
Yes. Adalimumab is a prescription-only biologic medicine.
Can Adalimumab increase infection risk?
Yes. Because it suppresses immune activity, patients should be screened for infections (e.g., TB) before starting therapy.
⚠️ Medical Disclaimer
This content is for educational and ecommerce listing purposes only. Adalimumab (Adali) is a prescription biologic medicine and must be used only under the supervision of a qualified healthcare professional.
